扶桑薬品工業(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|---|---|---|
東証PRM | 医薬品 | 4538/E00953 | Fuso Pharmaceutical Industries, Ltd. |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|---|---|---|---|---|---|---|---|---|
2017/04/21 | 日証協 | 37,617株 | -1.83% | 7,900株 | -16.79% | 43,045株 | -6.52% | 1,600株 | -79.75% |
2017/04/14 | 日証協 | 38,317株 | -0.78% | 9,494株 | -48.68% | 46,045株 | +12.73% | 7,900株 | +75.56% |
2017/04/07 | 日証協 | 38,617株 | -11.06% | 18,500株 | -21.61% | 40,845株 | -2.78% | 4,500株 | -76.23% |
2017/03/31 | 日証協 | 43,417株 | +28.39% | 23,600株 | +39.64% | 42,011株 | +15.59% | 18,935株 | +238.12% |
2017/03/24 | 日証協 | 33,817株 | -20.78% | 16,900株 | -19.52% | 36,346株 | -5.95% | 5,600株 | +1.82% |
2017/03/17 | 日証協 | 42,685株 | +8.93% | 21,000株 | +144.19% | 38,646株 | -8.3% | 5,500株 | +27.91% |
2017/03/10 | 日証協 | 39,185株 | -4.16% | 8,600株 | -77.54% | 42,146株 | -16.78% | 4,300株 | -79.02% |
2017/03/03 | 日証協 | 40,885株 | -18.23% | 38,285株 | +7.24% | 50,646株 | +11.44% | 20,500株 | +7.33% |
2017/02/24 | 日証協 | 50,000株 | +39.66% | 35,700株 | +441.4% | 45,446株 | +24.01% | 19,100株 | +180.88% |
2017/02/17 | 日証協 | 35,800株 | +7.19% | 6,594株 | +199.73% | 36,646株 | +0.55% | 6,800株 | +21.43% |
2017/02/10 | 日証協 | 33,400株 | -8.49% | 2,200株 | -80% | 36,446株 | -8.08% | 5,600株 | -8.2% |
2017/02/03 | 日証協 | 36,500株 | +1.39% | 11,000株 | -42.71% | 39,651株 | 0% | 6,100株 | +15.09% |
2017/01/27 | 日証協 | 36,000株 | +10.43% | 19,200株 | +772.73% | 39,651株 | +10.28% | 5,300株 | +3.92% |
2017/01/20 | 日証協 | 32,600株 | -0.91% | 2,200株 | -71.05% | 35,956株 | +1.12% | 5,100株 | +104% |
2017/01/13 | 日証協 | 32,900株 | -8.1% | 7,600株 | +1166.67% | 35,556株 | -7.3% | 2,500株 | -13.79% |
2017/01/06 | 日証協 | 35,800株 | +2.58% | 600株 | 0% | 38,356株 | +8.79% | 2,900株 | +123.08% |
2016/12/30 | 日証協 | 34,900株 | -0.85% | 600株 | -14.29% | 35,257株 | -6.62% | 1,300株 | -43.48% |
2016/12/22 | 日証協 | 35,200株 | +1.15% | 700株 | -92.13% | 37,757株 | 0% | 2,300株 | +91.67% |
2016/12/16 | 日証協 | 34,800株 | +14.47% | 8,900株 | +9.88% | 37,757株 | +1.89% | 1,200株 | -7.98% |
※株式分割は考慮していませんのでご注意ください。